C. elegans as a Model for Telomere Maintenance in Cancer
C. elegans as a Model for Telomere Maintenance in Cancer
批准号:
7939940
负责人:
Jan Karlseder
金额:
$38.66万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2013-08-31
关键词:
Adverse effectsAgeAgingAnimalsBindingBiological ModelsCaenorhabditis elegansCell CycleCell Cycle ProgressionCellsCessation of lifeChromosomal StabilityChromosomesCo-ImmunoprecipitationsComplexDataDatabasesDevelopmentDiseaseGenerationsGeneticGenetic RecombinationGoalsGrowthHomologous GeneHumanIndividualInvestigationLaboratoriesLearningLengthMaintenanceMalignant NeoplasmsMammalsModelingMolecularMusNematodaOrganismPathway interactionsPopulationProteinsRegulationResearchReverse TranscriptionRoleScreening procedureSolid NeoplasmStructureSystemTERF1 geneTINF2 geneTailTelomeraseTelomerase inhibitionTelomere Length MaintenanceTelomere MaintenanceTelomere PathwayTelomere ShorteningTestingTimeTranslatingYeastsbasecancer cellcancer therapycombatdesignexpectationinhibitor/antagonistmemberneoplastic cellnoveloffspringprotein complexpublic health relevanceresponsetelomeretooltumortumor growthtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomeres are specialized structures at the ends of linear chromosomes that protect them from enzymatic attack and preserve chromosome stability. During the growth of human cells the telomeres shorten with every division until they reach a critical length. Such short telomeres become dysfunctional, lose their protective features, and the cells recognize them and respond with permanent arrest or death. Consequently, replication associated telomere-shortening represents a powerful tumor suppressive mechanism, evidenced by the fact that almost all human tumors find a way to maintain their telomeres at a constant length. Tumor cells activate one of two potential pathways to counteract telomere shortening. 90% of cancers up-regulate the telomerase complex, capable of elongating telomeres by reverse transcription. 10% of tumors activate a recombination-based mechanism termed ALT. While fewer tumors initially rely on ALT, it can be considered the dominant mechanism, since ALT can be initiated upon inhibition of telomerase, rendering targeting of telomerase as cancer therapy without effect. While models such as yeast, mice and human cells have emphasized the importance of telomeres for cellular and organismal survival, they have so far failed to provide detailed information about regulation of both, telomerase and ALT. Furthermore, no multicellular system for studying the role of ALT in aging and cancer is available. Here I propose to take advantage of our finding that C. elegans telomeres represent primitive telomeres that rely on and regulate ALT as well as telomerase. I hypothesize that nematode telomeric proteins are regulators of these pathways, and that we can take advantage of them to understand the roles of ALT in organismal survival and tumorigenesis. AIM 1 is designed to isolate the complexes that regulate telomerase and ALT, to characterize the individual proteins in the complex, and to analyze their telomeric functions in detail. AIM 2 is designed to investigate the generation and maintenance of telomeric C and G overhangs in nematodes and mammals in detail, based on the hypothesis that C overhangs are defining features of ALT cells. In AIM 3 we will study how ALT can replace telomerase as telomere maintenance mechanism in a multicellular system. We have generated such an organism; we will characterize it and use it as a screening tool for regulators of the ALT pathway. In summary, this proposal suggests to establish C. elegans as a model system for telomere maintenance in cancer, and to translate between findings in nematodes and cancer cells.
PUBLIC HEALTH RELEVANCE: Cancer is an extremely variable disease, and the multiple different tumor types share few common aspects that can be targeted for therapy. Given that all cancers need to find a way to maintain telomere length in order to obtain immortality, telomeres, the natural ends of linear chromosomes, represent one of these universal targets. This proposal consists of three specific aims designed to understand telomere length maintenance mechanisms in the more primitive regulative system of the nematode C elegans, which can be decoded more efficiently, with the final goal of the development of inhibitors of these pathways as cancer therapy tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries
-
批准号:10709000
-
项目类别:
-
资助金额:$61.33万
-
财政年份:2022
-
负责人:Jan Karlseder
-
依托单位:
A nucleus-to-mitochondria nucleic acid-sensing pathway prevents bypass of age-associated proliferative boundaries
-
批准号:10587704
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2022
-
负责人:Jan Karlseder
-
依托单位:
Spontaneous replication fork collapse regulates telomere length homeostasis in wild type yeast
-
批准号:10371165
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2021
-
负责人:Jan Karlseder
-
依托单位:
Spontaneous replication fork collapse regulates telomere length homeostasis in wild type yeast
-
批准号:10549328
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2021
-
负责人:Jan Karlseder
-
依托单位:
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis
-
批准号:10529309
-
项目类别:
-
资助金额:$62.6万
-
财政年份:2019
-
负责人:Jan Karlseder
-
依托单位:
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis
-
批准号:10296665
-
项目类别:
-
资助金额:$62.6万
-
财政年份:2019
-
负责人:Jan Karlseder
-
依托单位:
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis
-
批准号:9888219
-
项目类别:
-
资助金额:$63.88万
-
财政年份:2019
-
负责人:Jan Karlseder
-
依托单位:
Understanding the role of autophagy-regulated cell death in the escape from replicative crisis
-
批准号:10063861
-
项目类别:
-
资助金额:$63.88万
-
财政年份:2019
-
负责人:Jan Karlseder
-
依托单位:
Understanding DNA break repair pathway choice regulation by the cNHEJ inhibitor CYREN
-
批准号:10397557
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2018
-
负责人:Jan Karlseder
-
依托单位:
Understanding DNA break repair pathway choice regulation by the cNHEJ inhibitor CYREN
-
批准号:10153737
-
项目类别:
-
资助金额:$44.01万
-
财政年份:2018
-
负责人:Jan Karlseder
-
依托单位:
The role of histone chaperone Asf1 in Alternative Lengthening of Telomeres
-
批准号:8824891
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Jan Karlseder
-
依托单位:
The role of histone chaperone Asf1 in Alternative Lengthening of Telomeres
-
批准号:8633024
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2013
-
负责人:Jan Karlseder
-
依托单位:
The role of histone chaperone Asf1 in Alternative Lengthening of Telomeres
-
批准号:8480331
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Jan Karlseder
-
依托单位:
The role of histone chaperone Asf1 in Alternative Lengthening of Telomeres
-
批准号:9243225
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Jan Karlseder
-
依托单位:
Understanding ALT activation in C. elegans and human cells
-
批准号:8773996
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2009
-
负责人:Jan Karlseder
-
依托单位:
Understanding ALT activation in C. elegans and human cells
-
批准号:9278180
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2009
-
负责人:Jan Karlseder
-
依托单位:
Understanding ALT activation in C. elegans and human cells
-
批准号:8878291
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2009
-
负责人:Jan Karlseder
-
依托单位:
C. elegans as a Model for Telomere Maintenance in Cancer
-
批准号:8324216
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2009
-
负责人:Jan Karlseder
-
依托单位:
C. elegans as a Model for Telomere Maintenance in Cancer
-
批准号:8136533
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2009
-
负责人:Jan Karlseder
-
依托单位:
Telomeric Function in Aging Syndromes
-
批准号:7268835
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2006
-
负责人:Jan Karlseder
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: